Our study sheds new light on the molecular mechanism of the PVT1/4EBP1 interaction in the tumorigenesis of cSCC, and provides a promising targeted therapeutic strategy for cSCC in the future. The gene discussed is PVT1; the disease is skin squamous cell carcinoma.